ShenZhen KYD Biomedical Technology Co., Ltd. clinical trials
Acquired by Shenzhen Salubris Pharmaceuticals Co., Ltd., Nov 30, 2015 · source ↗
The registry lists 1 studies whose lead sponsor is ShenZhen KYD Biomedical Technology Co., Ltd.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 29, 2023.
Before and after it joined Shenzhen Salubris Pharmaceuticals Co., Ltd.
- First submitted before ShenZhen KYD Biomedical Technology Co., Ltd. became part of Shenzhen Salubris Pharmaceuticals Co., Ltd.
- 0
- First submitted after ShenZhen KYD Biomedical Technology Co., Ltd. became part of Shenzhen Salubris Pharmaceuticals Co., Ltd.
- 1
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- ShenZhen KYD Biomedical Technology Co., Ltd.1 study
Something wrong with this grouping? Tell us on the Shenzhen Salubris Pharmaceuticals Co., Ltd. page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Shenzhen Salubris Pharmaceuticals Co., Ltd. studies →
- SaExten Vena Cava Filter System in Prevention of Pulmonary EmbolismCompletedNCT04948502Not applicable
Sponsor listed in the registry: ShenZhen KYD Biomedical Technology Co., Ltd. · First submitted after ShenZhen KYD Biomedical Technology Co., Ltd. became part of Shenzhen Salubris Pharmaceuticals Co., Ltd.